Cholesterol Testing Products and Services Market Size & Growth Forecast 2027–2036, By Segments (Product, Age Group, Service Provider, Test, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Cholesterol Testing Products and Services Market size was over USD 22.87 billion in 2026 and is likely to grow at a 7.98% CAGR between 2027 and 2036, crossing USD 49.28 billion by 2036. The industry revenue for 2027 is calculated at USD 24.41 billion.
Get more details on this report
Request Free Sample ReportCholesterol Testing Products and Services Market Intelligence Snapshot
Regional Market Dynamics
- North America holds 41.98% share, supported by established diagnostic infrastructure, routine preventive screening, and widespread cholesterol monitoring for cardiovascular risk management across healthcare settings.
- Asia Pacific is growing at 9.49% CAGR, driven by expanding healthcare access, rising screening uptake, and increasing integration of cholesterol testing into routine cardiometabolic care pathways.
Segment Momentum
- Testing Kits lead with 48.55% share as they provide complete, ready-to-use solutions with standardized procedures, bundled components, and simplified cholesterol measurement across clinical and at-home testing environments.
- Adult segment grows fastest as preventive cholesterol monitoring expands beyond older populations, driven by increasing health awareness and routine screening adoption among working-age users, making testing more routine earlier in the health cycle.
Market Expansion Drivers
- Rising preventive healthcare awareness increasing demand for routine cholesterol screening services.
- Expanding adoption of point-of-care and home testing devices improving accessibility of lipid diagnostics.
- Aging population and cardiovascular risk prevalence driving long-term diagnostic testing demand.
Leading Market Participants
- Top companies in the cholesterol testing products and services market include Quest Diagnostics Incorporated (United States), Laboratory Corporation of America Holdings (United States), Thermo Fisher Scientific Inc. (United States), Eurofins Scientific SE (Luxembourg), Randox Laboratories Ltd. (United Kingdom), SYNLAB AG (Germany), BioReference Health, LLC (United States), Clinical Reference Laboratory, Inc. (United States), Abbott Laboratories (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 22.87 billion
- 2027 Estimated Market Size: USD 24.41 billion.
- Projected Market Size: USD 49.28 billion by 2036
- Growth Forecast: 7.98% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Testing Kits (Product) | Geriatric (Age Group) | Hospitals and Clinics (Service Provider) | Total Cholesterol Tests (Test) | Cardiovascular Diseases (Application)
- Emerging Opportunity Segment: Testing Strips (Product) | Adult (Age Group) | Diagnostic Laboratories (Service Provider) | Low Density Lipoprotein (LDL) Cholesterol Tests (Test) | Obesity (Application)
Market Growth Drivers and Industry Trends
Rising preventive healthcare awareness increasing demand for routine cholesterol screening services
Greater emphasis on preventive healthcare is strengthening demand across the cholesterol testing products and services market as individuals and healthcare providers place greater importance on identifying cardiovascular risk before serious complications develop. Routine cholesterol screening helps assess lipid levels and supports earlier identification of abnormalities that may require lifestyle changes, monitoring, or clinical intervention. Increasing health awareness is also encouraging consumers to participate more actively in regular health checkups, while primary care providers are incorporating lipid assessments into preventive health programs. Broader awareness of the relationship between elevated cholesterol and cardiovascular conditions is supporting more frequent screening among health-conscious populations and individuals with recognized risk factors.
Expanding adoption of point-of-care and home testing devices improving accessibility of lipid diagnostics
Improved accessibility to diagnostic testing is creating additional opportunities in the cholesterol testing products and services market, particularly through point-of-care and home-based testing solutions. Portable devices can provide lipid measurements closer to the patient, reducing dependence on conventional laboratory visits and making testing more convenient for routine monitoring. Healthcare facilities can use point-of-care systems to support faster clinical assessment, while home testing technologies enable individuals to monitor cholesterol levels with greater flexibility. This convenience is particularly relevant for people requiring repeated lipid assessments, as simplified testing can encourage continued monitoring and reduce logistical barriers associated with traditional diagnostic pathways.
Aging population and cardiovascular risk prevalence driving long-term diagnostic testing demand
An expanding aging population, combined with the continued prevalence of cardiovascular risk factors, is increasing the need for ongoing lipid monitoring and diagnostic assessment. Older adults are more likely to undergo regular health evaluations in which cholesterol testing forms an important component of cardiovascular risk assessment, supporting sustained utilization in the cholesterol testing products and services market. At the same time, conditions and lifestyle factors associated with cardiovascular risk can require repeated testing to evaluate changes in lipid profiles and guide clinical management. The need for longitudinal monitoring also supports demand for accessible testing solutions across hospitals, outpatient facilities, diagnostic centers, and other healthcare settings.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising preventive healthcare awareness increasing demand for routine cholesterol screening services | 2.20% | High | North America, Asia Pacific | High | Near Term |
| Expanding adoption of point-of-care and home testing devices improving accessibility of lipid diagnostics | 1.90% | Moderate | North America, Europe | High | Mid Term |
| Aging population and cardiovascular risk prevalence driving long-term diagnostic testing demand | 1.60% | Moderate | Asia Pacific, Europe | High | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the cholesterol testing products and services market at 41.98% in 2026, supported by widespread preventive healthcare practices, established diagnostic infrastructure, and strong awareness of cardiovascular disease risk. Routine screening across hospitals, laboratories, physician offices, and other healthcare settings sustains demand for cholesterol testing. Continued emphasis on early detection and risk management, together with access to advanced diagnostic technologies, further reinforces the region's market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region for the cholesterol testing products and services market, driven by rising cardiovascular health awareness, expanding healthcare access, and growing demand for preventive diagnostics. Increasing urbanization and lifestyle-related health risks are encouraging more individuals to undergo routine health screening, while improvements in laboratory infrastructure are broadening access to testing services. Greater healthcare investment and the expansion of diagnostic capabilities across emerging economies are also supporting regional adoption.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Diagnostic Care IntegrationGermany incorporates cholesterol testing into structured preventive care and chronic disease management programs. German healthcare providers increasingly adopt efficient diagnostic services that support timely assessment and ongoing cardiovascular health monitoring.
France 🇫🇷
Preventive Laboratory ServicesFrance emphasizes cholesterol testing through coordinated primary care and laboratory-based preventive health programs. French healthcare providers increasingly focus on accessible diagnostic services that support early identification of cardiovascular risk factors.
Italy 🇮🇹
Community Health ScreeningItaly strengthens cholesterol testing through community-based preventive healthcare initiatives and expanded laboratory services. Italian healthcare providers increasingly encourage routine lipid assessment to improve long-term cardiovascular disease management and patient awareness.
Japan 🇯🇵
Routine Wellness MonitoringJapan promotes cholesterol testing through regular health examinations and proactive disease prevention initiatives. Healthcare institutions in Japan increasingly emphasize reliable diagnostic accuracy and convenient testing services that encourage continuous patient monitoring.
South Korea 🇰🇷
Digital Health DiagnosticsSouth Korea integrates cholesterol testing with digital healthcare services and preventive screening initiatives. Healthcare providers increasingly expand access to efficient diagnostic solutions that support personalized cardiovascular risk assessment and follow-up care.
United States 🇺🇸
Preventive Health ScreeningThe U.S. cholesterol testing products and services market benefits from strong emphasis on preventive healthcare and cardiovascular risk management. Healthcare providers in the U.S. continue expanding routine lipid screening through laboratory services and point-of-care diagnostic solutions.
Segment Leadership and Growth Trends
Cholesterol Testing Products and Services Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Testing Kits (Largest Segment) vs Testing Strips (Fastest-Growing Segment)
Testing kits segment held the largest share of the product category in the cholesterol testing products and services market, accounting for 48.55% in 2026. Their strong position is supported by the convenience of integrated testing solutions that can provide users with the materials and components needed to conduct cholesterol assessments efficiently. Growing awareness of preventive health monitoring and the importance of regular cholesterol evaluation is encouraging wider use of accessible testing products across healthcare and personal monitoring settings.
Testing strips are expected to be the fastest-growing product type, driven by their portability, ease of use, and suitability for rapid cholesterol monitoring. Their compact format can support convenient testing outside conventional clinical environments, making them attractive for individuals seeking more accessible health-management solutions. Increasing interest in self-monitoring and decentralized testing is creating further opportunities for testing strips as consumers and healthcare providers prioritize faster and more convenient assessment methods.
Age Group Segment Analysis: Geriatric (Largest Segment) vs Adult (Fastest-Growing Segment)
Geriatric segment represented the largest share of the age group category in the cholesterol testing products and services market, reaching 49.71% in 2026. The segment's strong position is associated with the greater need for ongoing cardiovascular risk assessment and routine health monitoring among older populations. Regular cholesterol testing can support preventive healthcare practices and help facilitate timely management of cardiovascular risk factors, reinforcing demand for testing products and related services among geriatric populations.
Adult segment is projected to be the fastest-growing age group as preventive health awareness expands beyond older populations. Increasing interest in identifying cardiovascular risk earlier, combined with greater accessibility of convenient cholesterol-testing solutions, is encouraging adults to incorporate regular monitoring into broader wellness routines. The shift toward proactive health management and accessible testing is expected to support stronger adoption among the adult population.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Testing Kits, Testing Strips, Others | Testing Kits | Testing Strips |
| Age Group | Geriatric, Adult, Pediatric | Geriatric | Adult |
| Service Provider | Hospitals and Clinics, Diagnostic Laboratories, Ambulatory Care Centers, Others | Hospitals and Clinics | Diagnostic Laboratories |
| Test | Total Cholesterol Tests, High Density Lipoprotein (HDL) Cholesterol Tests, Low Density Lipoprotein (LDL) Cholesterol Tests, Triglyceride Tests, Others | Total Cholesterol Tests | Low Density Lipoprotein (LDL) Cholesterol Tests |
| Application | Cardiovascular Diseases, Diabetes, Obesity, Hyperlipidemia, Others | Cardiovascular Diseases | Obesity |
Competitive Landscape and Market Positioning
Leading companies in the cholesterol testing products and services market:
1. Quest Diagnostics Incorporated (United States)
2. Laboratory Corporation of America Holdings (United States)
3. Thermo Fisher Scientific Inc. (United States)
4. Eurofins Scientific SE (Luxembourg)
5. Randox Laboratories Ltd. (United Kingdom)
6. SYNLAB AG (Germany)
7. BioReference Health LLC (United States)
8. Clinical Reference Laboratory Inc. (United States)
9. Abbott Laboratories (United States)
The cholesterol testing products and services market is evolving through advancements in rapid diagnostics and improved testing accessibility. Industry participants are emphasizing faster result delivery, portable testing formats, and enhanced accuracy to support preventive healthcare initiatives. Competitive differentiation is increasingly tied to integrated digital reporting features and consumer-friendly testing experiences designed to improve engagement in routine health monitoring.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Quest Diagnostics Incorporated (United States) | |||||||
| Laboratory Corporation of America Holdings (United States) | |||||||
| Thermo Fisher Scientific Inc. (United States) | |||||||
| Eurofins Scientific SE (Luxembourg) | |||||||
| Randox Laboratories Ltd. (United Kingdom) | |||||||
| SYNLAB AG (Germany) | |||||||
| BioReference Health LLC (United States) | |||||||
| Clinical Reference Laboratory Inc. (United States) | |||||||
| Abbott Laboratories (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Industry | 2026 | The market is shifting from centralized lab testing to point-of-care, home-based monitoring, and wearables. Digital connectivity is now a standard, with roughly 58% of new devices featuring wireless data integration and 41% of point-of-care analyzers incorporating Bluetooth for real-time health monitoring. |
| Novartis | Oct-24 | Novartis launched an innovative therapy in the Philippines to reduce LDL cholesterol, complementing a broader global push for preventive cardiovascular care. |
| Verichem Laboratories | Oct-24 | Verichem Laboratories introduced new liquid-stable reference materials for cholesterol assay calibration, improving the precision and quality assurance of total cholesterol, HDL, and LDL diagnostic testing. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Cholesterol Testing Products and Services Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Testing Technology | Laboratory-Based Testing, Point-of-Care Testing, Home-Based Testing, Wearable & Continuous Monitoring |
| Sample Type | Venous Blood, Capillary Blood, Dried Blood Spot, Other Sample Types |
| Testing Frequency | One-Time/Occasional Testing, Annual Testing, Semi-Annual Testing, Quarterly or More Frequent Testing |
Cholesterol Testing Products and Services Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Preventive Screening Program Opportunity Assessment |
|
| Diagnostic Care Pathway and Referral Analysis |
|
| Point-of-Care Testing Adoption Assessment |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current size of the cholesterol testing products and services market?
What is the projected value of the cholesterol testing products and services industry by 2036?
How is preventive healthcare adoption influencing demand patterns in the cholesterol testing products and services market?
What impact is point-of-care and home testing adoption having on the cholesterol testing products and services market?
Why do testing kits dominate the cholesterol testing products and services market?
Why is the adult segment the fastest-growing in the cholesterol testing products and services market?
Why does North America lead the cholesterol testing market?
What is driving Asia Pacific’s rapid growth in this market?
Who are the leading players in the cholesterol testing products and services landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization